WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”
Address:
6 Cedarbrook Drive
Cranbury NJ 08512
Email: [email protected]
Phone number:
609-606-6666
Link to contact page: https://labtesting.wuxiapptec.com/contact-us/
Integrated bioanalytical strategy for LNP-mRNA products
Challenges and solutions in bioanalysis for oligonucleotide drugs
Bioanalysis of gene and cell therapeutic products in new biotechnology era
Bioanalytical applications of inductively coupled plasma mass spectrometer (ICP-MS)
AAPS 2025 Pharmsci 360
November 9-12
San Antonio, TX
European BioForum 2025
November 18-20
Barcelona, Spain
Get to know WuXi AppTec!
LinkedIn (Lab testing division)
Link to WuXi AppTec website: https://labtesting.wuxiapptec.com/